P&G Comfortable As "Niche" Rx Firm: Buys Clairol For Cash, Not Swap

Procter & Gamble is comfortable with its position as a "niche" player in the pharmaceutical industry over the short term, CEO A.G. Lafley said during a May 21 analysts meeting discussing the acquisition of Clairol from Bristol-Myers Squibb.